PARIS, February 4, 2013 /PRNewswire/ -- - Sanofi portfolio expands to offer first once-a-day prandial GLP-1 receptor agonist - Sanofi (EURONEXT : SAN and NYSE : SNY) announced today that the European Commission has granted Marketing Authorisation in Europe for...
Reported by PR Newswire 1 day ago.
↧